Hovav Nechushtan Selected Research

Pyruvate Kinase

8/2010

Circulating tumor M2 pyruvate kinase and thymidine kinase 1 are potential predictors for disease recurrence in renal cell carcinoma after nephrectomy.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Hovav Nechushtan Research Topics

Disease

35	Neoplasms (Cancer) 03/2024 - 08/2002
16	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 03/2024 - 02/2012
11	Lung Neoplasms (Lung Cancer) 09/2023 - 03/2013
8	Breast Neoplasms (Breast Cancer) 06/2023 - 08/2002
4	Neoplasm Metastasis (Metastasis) 01/2017 - 08/2014
3	Brain Neoplasms (Brain Tumor) 01/2022 - 01/2020
2	Neuroendocrine Tumors (Neuroendocrine Tumor) 01/2023 - 01/2017
2	Triple Negative Breast Neoplasms 01/2023 - 08/2014
2	Colorectal Neoplasms (Colorectal Cancer) 01/2022 - 02/2012
2	Adenocarcinoma of Lung 01/2022 - 02/2012
2	Sarcoma (Soft Tissue Sarcoma) 01/2021 - 08/2002
2	Carcinoma (Carcinomatosis) 01/2017 - 08/2002
2	Renal Cell Carcinoma (Grawitz Tumor) 04/2016 - 08/2010
2	Cardiomegaly (Heart Hypertrophy) 09/2015 - 10/2006
2	B-Cell Lymphoma (Lymphoma, B Cell) 01/2010 - 11/2009
2	Body Weight (Weight, Body) 10/2006 - 08/2002
1	Urinary Bladder Neoplasms (Bladder Cancer) 01/2023
1	Carcinoid Tumor (Carcinoid) 01/2023
1	Dermatomyositis (Dermatopolymyositis) 09/2021
1	Disease Progression 01/2020
1	Microsatellite Instability 01/2018
1	Small Cell Lung Carcinoma (Small Cell Lung Cancer) 02/2016
1	Heart Failure 09/2015

Drug/Important Bio-Agent (IBA)

5	PlatinumIBA 09/2023 - 01/2017
5	osimertinibIBA 01/2023 - 01/2020
4	ErbB Receptors (EGF Receptor)IBA 01/2023 - 01/2020
4	Tyrosine Kinase InhibitorsIBA 04/2022 - 05/2010
3	pembrolizumabIBA 01/2022 - 01/2017
3	Phosphotransferases (Kinase)IBA 01/2021 - 11/2008
3	LigandsIBA 01/2021 - 09/2015
3	Tyrosine (L-Tyrosine)FDA Link 01/2021 - 04/2013
3	thymidine kinase 1IBA 04/2016 - 08/2010
2	Immune Checkpoint InhibitorsIBA 03/2024 - 01/2023
2	Cisplatin (Platino)FDA LinkGeneric 01/2023 - 04/2015
2	Biomarkers (Surrogate Marker)IBA 01/2023 - 11/2019
2	DNA (Deoxyribonucleic Acid)IBA 01/2023 - 02/2009
2	big gastrinIBA 01/2023 - 02/2016
2	Peptides (Polypeptides)IBA 01/2023 - 02/2016
2	Protein-Tyrosine Kinases (Tyrosine Kinase)IBA 01/2022 - 01/2021
2	Mitogen-Activated Protein Kinase Kinases (MEKs)IBA 01/2022 - 01/2019
2	Drug CombinationsIBA 01/2022 - 01/2021
2	Proteins (Proteins, Gene)FDA Link 01/2021 - 01/2021
2	Lysine-tRNA LigaseIBA 11/2018 - 09/2017
2	Serine (L-Serine)FDA Link 11/2018 - 09/2017
2	Microphthalmia-Associated Transcription FactorIBA 09/2015 - 09/2002
2	Cytotoxins (Cytolysins)IBA 10/2014 - 05/2008
2	Interleukin-4 (Interleukin 4)IBA 11/2009 - 04/2005
2	OvalbuminIBA 05/2008 - 10/2007
1	ProteomeIBA 03/2024
1	Adenine NucleotidesIBA 09/2023
1	Ribose (D-Ribose)IBA 09/2023
1	selpercatinibIBA 01/2023
1	HexosesIBA 01/2023
1	Histone Deacetylase InhibitorsIBA 01/2023
1	durvalumabIBA 01/2023
1	Valproic Acid (Depakote)FDA LinkGeneric 01/2023
1	Chromogranin AIBA 01/2023
1	Poly(ADP-ribose) Polymerase InhibitorsIBA 11/2022
1	talazoparibIBA 11/2022
1	AutoantibodiesIBA 09/2021
1	Paclitaxel (Taxol)FDA LinkGeneric 01/2021
1	Anaplastic Lymphoma KinaseIBA 01/2021
1	CrizotinibIBA 01/2021
1	Alanine Transaminase (SGPT)IBA 01/2021
1	human ERBB2 proteinIBA 01/2021
1	Protein Serine-Threonine Kinases (Protein-Serine-Threonine Kinase)IBA 01/2021
1	Aspartate Aminotransferases (Aspartate Transaminase)IBA 01/2021
1	Gefitinib (Iressa)FDA Link 01/2020
1	Erlotinib Hydrochloride (CP 358,774)FDA Link 01/2020
1	Platinum Compounds (Compounds, Platinum)IBA 11/2019
1	Receptor Protein-Tyrosine Kinases (Tyrosine Kinase Receptors)IBA 12/2018
1	B7-H1 AntigenIBA 01/2018
1	1,4,7,10-tetraazacyclododecane- 1,4,7,10-tetraacetic acidIBA 01/2017
1	cabozantinibIBA 11/2016
1	pro-gastrin-releasing peptide (31-98)IBA 02/2016
1	NivolumabIBA 01/2016
1	MicroRNAs (MicroRNA)IBA 06/2015
1	Vinorelbine (Navelbine)FDA LinkGeneric 04/2015
1	Disulfiram (Antabuse)FDA Link 04/2015
1	Growth Factor ReceptorsIBA 10/2014
1	Taxoids (Taxanes)IBA 08/2014
1	Cetuximab (Erbitux)FDA Link 08/2014
1	taxaneIBA 08/2014
1	ParaffinIBA 02/2012
1	Formaldehyde (Formol)FDA Link 02/2012
1	EnzymesIBA 08/2010
1	Pyruvate KinaseIBA 08/2010
1	Imatinib Mesylate (Gleevec)FDA Link 05/2010
1	pazopanib FDA Link 05/2010
1	masitinibIBA 05/2010

Therapy/Procedure

18	Therapeutics 03/2024 - 05/2008
11	Drug Therapy (Chemotherapy) 03/2024 - 11/2009
4	Radiotherapy 03/2024 - 10/2014
2	Immunotherapy 03/2024 - 01/2021
2	Nephrectomy 04/2016 - 08/2010
1	Transurethral Resection of Bladder 01/2023
1	Precision Medicine 01/2021
1	Time-to-Treatment 01/2021
1	Radiofrequency Ablation 04/2016
1	Adjuvant Chemotherapy 04/2013